1-3 of 3
Thomas Zander
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Primary results from VAYHIT2, a randomized, double-blind, phase 3 trial of ianalumab plus eltrombopag versus placebo plus eltrombopag in patients with primary immune thrombocytopenia (ITP) who failed first-line corticosteroid treatment

Free
Hanny Al-Samkari, Adam Cuker, Francesco Zaja, Marc Michel, Waleed Ghanima, Thomas Stauch, Lei Zhang, Ming Hou, Thomas Zander, Azizan Sharif, Jing Sun, Prof. Uttam Kumar Nath, Roger Schutgens, Elena Rossi, Lien Deleu, Libor Červinek, Jae-Ho Yoon, Hung Chang, Theera Ruchutrakool, Masaki Iino, Tatsunori Goto, Patrick Urban, Justyna Fronczek, Matthew Foster, Marine Weill, Nicola Cooper
Journal: Blood
Blood (2025) 146 (Supplement 2): LBA-2.
https://doi.org/10.1182/blood-2025-LBA-2
Published: 2025
Journal Articles

RNA fingerprints provide direct evidence for the inhibitory role of TGFβ and PD-1 on CD4 + T cells in Hodgkin lymphoma

Free
Jens M. Chemnitz, Daniela Eggle, Julia Driesen, Sabine Classen, James L. Riley, Svenja Debey-Pascher, Marc Beyer, Alexey Popov, Thomas Zander, Joachim L. Schultze
Journal: Blood
Blood (2007) 110 (9): 3226–3233.
https://doi.org/10.1182/blood-2006-12-064360
Published: 2007
Includes: Supplemental data
Journal Articles

Somatic Mutations Within the Untranslated Regions of Rearranged Ig Genes in a Case of Classical Hodgkin’s Disease as a Potential Cause for the Absence of Ig in the Lymphoma Cells

Free
Andrea Jox, Thomas Zander, Ralf Küppers, Johannes Irsch, Holger Kanzler, Martin Kornacker, Heribert Bohlen, Volker Diehl, Jürgen Wolf
Journal: Blood
Blood (1999) 93 (11): 3964–3972.
https://doi.org/10.1182/blood.V93.11.3964
Published: 1999